Aventis Pharma Deutschland GMBH v. Lupin Ltd.
District Court, E.D. Virginia
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
DOUMAR, District Judge.
This case involves alleged patent infringement on the part of a generic drug company. Plaintiffs Aventis Pharma Deutschland GMBH (“Aventis”) and King Pharmaceuticals, Inc. (“King”) have brought a two-count suit against Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. for patent infringement and inducement of infringement. Two matters are presently before this Court: 1) Plaintiffs’ Motion to Stay the Proceedings, and 2) Defendants’ Motion to Dismiss. For the reasons stated herein, these motions are DENIED.
I. Background
The action leading…
2Cases cited17 opinions
- Neitzke v. WilliamsSupreme Court of the United States · 1989
- Landis v. North American Co.Supreme Court of the United States · 1936
- Brenda Curtis and Alvin Williamson v. Citibank, N.A., Citicorp North America, Inc. And Citicorp SecuritiesCourt of Appeals for the Second Circuit · 2000
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- Ivan N. Schatz Joann B. Schatz v. Mark E. Rosenberg Mer Enterprises, Incorporated Stephen Jaeger Weinberg & GreenCourt of Appeals for the Fourth Circuit · 1991
12 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd.Court of Appeals for the Federal Circuit · 2012
- Pfizer Inc. v. Apotex Inc.District Court, N.D. Illinois · 2009
- Cephalon, Inc. v. Watson Pharmaceuticals, Inc.District Court, D. Delaware · 2009
- Wyeth v. Lupin Ltd.District Court, D. Maryland · 2007
- PBM Nutritionals, LLC v. Dornoch Ltd. Ex Rel. Underwriting Members of Lloyd's Syndicate 1209District Court, E.D. Virginia · 2009
5 more not listed; retrieve them via the Exa API.